Anastrozole: Side Effects, Dosage, Uses and More

And the studies were continued for an additional 5 years after the women stopped taking the drug. No new side effects were reported during this additional time. One large clinical study showed that Arimidex was more effective than the cancer drug tamoxifen in treating early HR+ breast cancer.

Here we look at how Arimidex and tamoxifen are alike and different. If you have questions about using Arimidex for uterine fibroids, talk with your doctor. However, Arimidex has been used off-label to reduce the size of fibroids and to help relieve pain that’s caused by them. The drug has also been given to reduce bleeding that’s caused by fibroids when other treatments haven’t worked.

Breast Cancer: Female Celebrities Who’ve Had Breast Cancer

A recent study examining safety and efficacy of combined use of CC and AI (anastrozole) confirmed the association of BMI with E2 levels. The authors further suggested that obese men may be more likely to develop hyperestrogenemia on CC monotherapy and may benefit from combination therapy. Their study, albeit small and retrospective in nature, found the combination therapy to be a safe and effective TT alternative [79]. A dose-finding study was performed to investigate if the FBA was able to detect possible effects of chronically administered genistein on fertility in this pharmacologically relevant concentration range. P4 production increased significantly in the presence of ≥2μmol l−1 genistein.

Anastrozole (Arimidex)is prescribed for post-surgical treatment of breast cancer in women who are postmenopausal. Side effects drug interactions, dosage, storage, and safety information should be reviewed prior to taking this medication. HR+ cancers can be treated with hormone therapies that lower the estrogen level in your body. And because most breast cancer is HR+, hormone therapies are also sometimes used to treat breast cancer whose receptor status isn’t known. But if these treatments don’t work to treat the endometrial cancer, a hormone therapy may be used to further reduce estrogen in your body.

Important Safety Information About ARIMIDEX

Serious birth defects can occur if you take this medication during pregnancy and for 3 weeks after the last dose. You will need a negative pregnancy test before starting this medication. Estrogen and progestin hormones may not work as well while you are taking this medication.

Arimidex and letrozole both contain a type of drug called an aromatase inhibitor. Therefore, these medications can cause very similar side effects. Arimidex for breast cancer Arimidex is FDA-approved to treat breast cancer in women who’ve gone through menopause. Clinical studies of Arimidex followed women with early breast cancer who took the drug for 5 years.

Women at moderate and increased risk of breast cancer should consider taking the drug, said Prof. Cuzick. However, he admitted that determining breast cancer risk was a challenge as there are many factors that can increase risk. The IBIS-II trial ran from February 2, 2003, to January 31, 2012, across 153 breast cancer treatment centers in 18 countries and recruited 3,864 post-menopausal women at high risk of breast cancer. When data from the two controlled trials are pooled, the objective response rates and median times to progression and death were similar for patients randomized to ARIMIDEX 1 mg and megestrol acetate.

Anastrozole side effects

However, questions remain regarding the best treatment regimen [15,16]. A total of 1021 patients between the ages of 30 and 92 years old were randomized to receive trial treatment. Patients were randomized to receive 1 mg of Anastrozole once daily or 20 mg of tamoxifen once daily. The primary endpoints for both trials were time to tumor progression, objective tumor response rate, and safety. Some of the patients had also received previous cytotoxic treatment. Most patients were ER-positive; a smaller fraction were ER-unknown or ER-negative; the ER-negative patients were eligible only if they had had a positive response to tamoxifen.

What Age Does Breast Cancer Usually Start?

Anastrozole is an aromatase inhibitor, which works to decrease the overall levels of estrogen in a woman’s body. In women who have gone through menopause, estrogen is mainly produced by converting androgens (sex hormones produced by the adrenal glands) into estrogens. An enzyme called aromatase is responsible for this conversion. Aromatase inhibitors block this conversion, leading to less estrogen in the body.

Genetic Testing: Families With Breast Cancer

In addition, the World Anti-Doping Agency lists Arimidex as a substance that’s prohibited for use in competitive sports. If you have questions about using Arimidex to prevent breast cancer, talk with your doctor. However, the American Cancer Society notes that the drug may be helpful for women with either endometrial cancer or endometrial stromal sarcoma. (Endometrial stromal sarcoma affects the uterine lining, as well as the muscular wall of your uterus.) But keep in mind that these are off-label uses of Arimidex. If you’d like to know more about using Arimidex for breast cancer before you’ve reached menopause, talk with your doctor. It’s important to note that Arimidex works by stopping the aromatase enzyme (type of protein) from working in your body.

Schreibe einen Kommentar

Deine E-Mail-Adresse wird nicht veröffentlicht. Erforderliche Felder sind mit * markiert

Dr. med. Sibylle Köhler

Curriculum Vitae

Seit 01.04.2020 Niedergelassen in eigener Praxis
01.11.2008 - 31.03.2020 im Angestelltenverhältnis niedergelassen
(Medikum Kassel und HNO-Praxis Schäfer)
09/2007 - 10/2008 Elternzeit
6/2007 Fachärztin für Hals-Nasen-Ohrenheilkunde
10/2006 Qualitätsnachweis Botulinumtoxin
2005 - 2007 Assistenzärztin im Petruskrankenhaus in Wuppertal
Dr. med. C.-P. Fues
2004 - 2005 Assistenzärztin im Klinikum Lüdenscheid
Dr. med. H. Davids
2001 - 2004 ÄiP und Assistenzärztin in der HNO-Uniklinik Göttingen
Prof. Dr. med. W. Steiner
1994 - 2001 Medizinstudium an der Georg-August-Universität Göttingen
1985 - 1994 Marienschule Hildesheim, Allgemeine Hochschulreife

Dr. med. Frank Schreiber

Curriculum Vitae

ab 01.04.2020 Niederlassung in eigener Praxis
Oberarzt, HNO, Klinikum Kassel,
bis 31.3.2020 Prof. Dr. med. U. Bockmühl
ab 01.07.2005 Prof. Dr. med. M. Schröder,
seit 01.09.2009 leitender Oberarzt
Oberarzt, HNO, Krankenhaus St. Georg, Hamburg
ab 01.07.1999 Prof. Dr. med. C. Morgenstern
bis 30.06.2005 Prof. Dr. med. J. von Scheel
01.10.1995 - 30.06.1999 Assistenzarzt, HNO, Universitätsklinik Mainz,
Prof. Dr. med. W. Mann
01.01.1995 - 30.05.1995 AiP, HNO, Dr.-Horst-Schmidt Kliniken Wiesbaden,
Prof. Dr. med. A. Beigel
05/1999 Facharzt für HNO
11/2011 Zusatzbezeichnung plastische Chirurgie
spezielle HNO Chirurgie
1978 - 1987 Friedrichsgymnasium Kassel, Allgemeine Hochschulreife


Marburger Str. 85 | 34127 Kassel

Klinikum Kassel

Mönchebergstraße 41-43 | 34125 Kassel

W19 HNO Praxis

Wilhelmsstraße 19 | 34117 Kassel